SARMs Guide: Selective Androgen Receptor Modulators in Research
Compounds known as selective androgen receptor modulators, or more commonly referred to as SARMs, have been studied in order to examine their interaction with the androgen receptor (AR). Although the term is often used broadly online, not all substances grouped as SARMs belong to the same pharmacological class or act through the same molecular target.
This guide explains what SARMs are, how androgen receptor signaling is studied, and why distinguishing between different research compounds matters when interpreting scientific literature.
Direct Sarms products are supplied strictly for laboratory research purposes and are not intended for human or animal consumption.
What Are SARMs?
SARMs are compounds investigated for their interaction with the androgen receptor, a member of the nuclear receptor family.
When a suitable ligand binds to an androgen receptor, the resulting receptor complex can influence the transcription of androgen-responsive genes. Researchers can study this process to examine how different compounds interact with the receptor and how those interactions affect downstream molecular signaling.
The term "selective" matters, but it can also be misleading if taken too literally. Since each SARM has its own chemical structure and pharmacological properties, they should not be regarded as interchangeable substances merely because they are associated with the androgen receptor.
How Are SARMs Studied?
Research into SARMs can examine several stages of androgen receptor activity, from initial ligand binding through to changes in gene transcription.
Depending on the research question, experimental work may investigate receptor affinity, receptor activation, transcriptional activity, molecular structure or the expression of androgen-responsive genes.
A simplified representation of this pathway is:
Ligand binding → androgen receptor activation → interaction with DNA → changes in androgen-responsive gene transcription
The response observed in an experiment can depend on the compound being investigated, the research model, and the endpoints being measured. This is why evidence associated with one SARM should not automatically be applied to another.
SARMs and Related Compounds in the Direct Sarms Research Range
The current Direct Sarms range includes a smaller selection of SARMs and related research compounds supplied in capsule and powder formats.
| Research compound | Classification or research target | Format |
|---|---|---|
| ACP-105 | Selective androgen receptor modulator | Capsules |
| AC-262,536 | Selective androgen receptor modulator | Capsules |
| LGD-4033 | Selective androgen receptor modulator | Capsules |
| S-4 (Andarine) | Selective androgen receptor modulator | Capsules and powder |
| YK-11 | Androgen receptor-active research compound | Powder |
| MK-2866 + GW501516 | Research compound blend | Capsules |
Explore SARMs Research Products
Availability may change over time. Current products, formats, and specifications can be found within the Direct Sarms research catalog.
Why Are Some Compounds Grouped with SARMs?
The term “SARM” is sometimes used loosely when compounds are discussed online. This can result in substances with different molecular targets being placed within the same group.
GW501516 is one example. It is often discussed alongside SARMs, but it is associated with peroxisome proliferator-activated receptor delta (PPARδ) rather than selective androgen receptor modulation.
The MK-2866 and GW501516 blended capsules therefore contain two research compounds associated with different molecular targets.
MK-677, also known as ibutamoren, provides another example. It is frequently grouped with SARMs in online discussions but is not a selective androgen receptor modulator. MK-677 is generally described as a growth hormone secretagogue and is listed separately within the Direct Sarms research range.
Understanding these distinctions is important when comparing compounds or reviewing published research. Similar commercial groupings do not necessarily indicate similar mechanisms.
Why Compound Classification Matters
Grouping every SARM and SARM-associated compound together can oversimplify the underlying pharmacology.
Two compounds may appear in the same area of research while differing in molecular structure, receptor interactions, and the pathways being investigated. Even compounds that both interact with the androgen receptor can have different experimental profiles.
Research should therefore be interpreted on a compound-by-compound basis, with attention paid to the methodology, model and endpoints used in each study.
This is particularly important when comparing older and newer research. The amount of published evidence available is not the same for every compound.
Research Status and Limitations
SARMs remain an area of ongoing pharmacological research. The type and extent of evidence available vary considerably between individual compounds.
Experimental findings can also be affected by factors such as methodology, research model, concentration, and the molecular or cellular endpoints being measured. Results from one experimental setting cannot necessarily be transferred to another.
SARMs are not FDA-approved medicines. Published research involving these compounds should not be interpreted as establishing their safety or effectiveness for human use.
Products available from Direct Sarms are supplied as research materials only and are not intended for human or animal consumption.
Frequently Asked Questions
Is every compound that is described as a SARM actually a SARM?
Not at all; some compounds are classified as SARMs even though they act on different molecular targets. For instance, GW501516 is linked to PPARδ and not to selective androgen receptor modulation.
Is MK-677 a SARM?
No. MK-677, also known as ibutamoren, is generally classified as a growth hormone secretagogue rather than a selective androgen receptor modulator.
What receptor do SARMs interact with?
SARMs are primarily investigated for their interaction with the androgen receptor (AR). This is a nuclear receptor involved in regulating androgen-responsive gene transcription.
Are all SARMs chemically the same?
No. Individual SARMs have different chemical structures and can differ in receptor affinity and other pharmacological characteristics. Research involving one compound should therefore not automatically be applied to another.
Are Direct Sarms research compounds intended for human use?
No. Direct Sarms research compounds are supplied strictly for laboratory research purposes and are not intended for human or animal consumption.
References
- Bhasin S, Jasuja R. Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):232-40. doi: 10.1097/MCO.0b013e32832a3d79. PubMed ↗
- Xie Y, Tian Y, Zhang Y, et al. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021). Eur J Med Chem. 2022 Feb 15;230:114119. doi: 10.1016/j.ejmech.2022.114119. PubMed ↗
Research Use Disclaimer
All content and product information provided by Direct Sarms is for educational and research purposes only.
Products supplied by Direct Sarms are intended solely for laboratory research and research development. They are not intended for human or animal use or consumption and should be handled only by suitably qualified professionals.
Products should not be classified, represented or used as medicines, foods, cosmetics or products intended to diagnose, treat, cure or prevent disease.